Tacrolimus News and Research

RSS
Tacrolimus is a drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.
Inhaled immunosuppressant could improve prognosis of lung transplant patients

Inhaled immunosuppressant could improve prognosis of lung transplant patients

Drug combination could improve survival of lung transplant patients

Drug combination could improve survival of lung transplant patients

New immunosuppressive regimens may improve outcomes for kidney transplant patients

New immunosuppressive regimens may improve outcomes for kidney transplant patients

Scientists discover how protein molecules regulate formation of myelin sheaths

Scientists discover how protein molecules regulate formation of myelin sheaths

Scientists develop more cost-effective way to culture stem cells

Scientists develop more cost-effective way to culture stem cells

Early and targeted treatment of dnDSA preserves allograft function

Early and targeted treatment of dnDSA preserves allograft function

Calcium controls use of glucose by T cells to multiply and battle against infection, study finds

Calcium controls use of glucose by T cells to multiply and battle against infection, study finds

Liver transplant patients who take new anti-rejection drug gain less weight, study finds

Liver transplant patients who take new anti-rejection drug gain less weight, study finds

New BSR guideline provides evidence-based recommendations for clinicians prescribing non-biologic DMARDs

New BSR guideline provides evidence-based recommendations for clinicians prescribing non-biologic DMARDs

Results of high-impact clinical trials could improve kidney-related medical care

Results of high-impact clinical trials could improve kidney-related medical care

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Investigators find tacrolimus to be very effective in reducing ocular symptoms of GVHD

Phenotypic personalized medicine can identify a person's optimal drug, dose combinations

Phenotypic personalized medicine can identify a person's optimal drug, dose combinations

Biomarkers may provide novel approaches to monitoring immunosuppressive therapy in organ transplant patients

Biomarkers may provide novel approaches to monitoring immunosuppressive therapy in organ transplant patients

Many kidney transplant patients may benefit from lower-than-standard dose of CNIs

Many kidney transplant patients may benefit from lower-than-standard dose of CNIs

Anti-aging Glycopeptide can improve efficacy of cell transplant treatments for diabetes patients

Anti-aging Glycopeptide can improve efficacy of cell transplant treatments for diabetes patients

Study suggests combination of MMF and CNIs can protect against rare lymphoma

Study suggests combination of MMF and CNIs can protect against rare lymphoma

Researchers link organ transplant drug to rise in rare lymphoma

Researchers link organ transplant drug to rise in rare lymphoma

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

FDA, EMA accept filing applications for Boehringer Ingelheim's afatinib to treat patients with advanced SCC of the lung

Envarsus XR granted FDA orphan drug designation for prophylaxis of organ rejection in kidney transplant patients

Envarsus XR granted FDA orphan drug designation for prophylaxis of organ rejection in kidney transplant patients

Envarsus XR receives FDA approval for treatment of kidney transplant recipients

Envarsus XR receives FDA approval for treatment of kidney transplant recipients